...
首页> 外文期刊>Canadian Journal of Infectious Diseases and Medical Microbiology: Journal Canadien des Maladies Infectieuses >The Impact of Serum Vancomycin Levels and Minimum Inhibitory Concentrations of Methicillin-Resistant Staphylococcus aureus on Mortality in Patients with Nosocomial Pneumonia
【24h】

The Impact of Serum Vancomycin Levels and Minimum Inhibitory Concentrations of Methicillin-Resistant Staphylococcus aureus on Mortality in Patients with Nosocomial Pneumonia

机译:院内肺炎患者血清万古霉素水平和耐甲氧西林金黄色葡萄球菌最低抑菌浓度对死亡率的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Vancomycin is the treatment of choice for methicillin-resistant Staphylococcus aureus (MRSA) infections; however, treatment failure is not uncommon, even when the minimum inhibitory concentration (MIC) of the MRSA strain is within the susceptible range for vancomycin.
机译:背景:万古霉素是耐甲氧西林金黄色葡萄球菌(MRSA)感染的首选治疗方法。然而,即使MRSA菌株的最低抑菌浓度(MIC)在万古霉素的易感范围内,治疗失败也不罕见。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号